Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
Authors:
Open Access
- 22 November 2019
- journal article
- research article
- Published by Wiley in HemaSphere
- Vol. 3 (6) , e321
Abstract
Myeloid neoplasms (MNs) with germline predisposition have recently been recognized as novel entities in the latest World Health Organization (WHO) classification for MNs. Individuals with MNs due to germline predisposition exhibit increased risk for the development of MNs, mainly acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Setting the diagnosis of MN with germline predisposition is of crucial clinical significance since it may tailor therapy, dictate the selection of donor for allogeneic hematopoietic stem cell transplantation (allo-HSCT), determine the conditioning regimen, enable relevant prophylactic measures and early intervention or contribute to avoid unnecessary or even harmful medication. Finally, it allows for genetic counseling and follow-up of at-risk family members. Identification of these patients in the clinical setting is challenging, as there is no consensus due to lack of evidence regarding the criteria defining the patients who should be tested for these conditions. In addition, even in cases with a strong suspicion of a MN with germline predisposition, no standard diagnostic algorithm is available. We present the first version of the Nordic recommendations for diagnostics, surveillance and management including considerations for allo-HSCT for patients and carriers of a germline mutation predisposing to the development of MNs.Keywords
This publication has 58 references indexed in Scilit:
- GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AMLLeukemia, 2018
- Germline alterations in a consecutive series of acute myeloid leukemiaLeukemia, 2018
- Pathogenic Germline Variants in 10,389 Adult CancersCell, 2018
- Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?Leukemia, 2018
- Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignanciesBlood Advances, 2018
- GATA2 deficiency and related myeloid neoplasmsSeminars in Hematology, 2017
- Patterns and functional implications of rare germline variants across 12 cancer typesNature Communications, 2015
- GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndromeBlood, 2013
- GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutationsBritish Journal of Haematology, 2013
- Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)Nature Genetics, 2011